NCT07628049
- Conditions
- Respiratory Syncytial Virus Infections+Metapneumovirus
- Locations
-
- GSK Investigational Site Lenexa, Kansas, United States
- GSK Investigational Site Seattle, Washington, United States
- GSK Investigational Site Botany, New South Wales, Australia
- GSK Investigational Site Camberwell, Victoria, Australia